Filing Details
- Accession Number:
- 0001209191-21-032358
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-13 16:36:12
- Reporting Period:
- 2021-05-11
- Accepted Time:
- 2021-05-13 16:36:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1664710 | Keros Therapeutics Inc. | KROS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1808322 | Jennifer Lachey | C/O Keros Therapeutics, Inc. 99 Hayden Avenue, Suite 120, Building E Lexington MA 02421 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-11 | 2,650 | $0.30 | 73,837 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-11 | 2,650 | $50.00 | 71,187 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-05-13 | 6,220 | $0.11 | 77,407 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-13 | 500 | $0.30 | 77,907 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-05-11 | 2,650 | $0.00 | 2,650 | $0.30 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-05-13 | 6,220 | $0.00 | 6,220 | $0.11 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-05-13 | 500 | $0.00 | 500 | $0.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 132,355 | 2028-03-25 | No | 4 | M | Direct | |
| 0 | 2027-04-02 | No | 4 | M | Direct | |
| 7,793 | 2028-03-25 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Immediately exercisable.
- One-twelfth (1/12th) of the shares subject to the option vested or shall vest in equal quarterly installments commencing on March 18, 2018, subject to the Reporting Person continuing to provide service through each such date.
Billionaire Hedge Funds
